Advertisement

Topics

Onyx Pharmaceuticals, Inc. Company Profile

15:03 EDT 26th March 2019 | BioPortfolio

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a next-generation proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors. ONX 0801, a targeted alpha-folate inhibitor, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing. For more information about Onyx, visit the company's website at www.onyx-pharm.com.


News Articles [429 Associated News Articles listed on BioPortfolio]

'Ridiculous' (in a Good Way) Results With Novel Stent

Both BIONYX and SORT OUT IX trials showed Resolute Onyx and BioFreedom stents noninferior to the Orsiro device, but stent thrombosis with Resolute Onyx was called 'ridiculously low' by one commentator...

[Articles] Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-b

The Resolute Onyx stent was non-inferior to Orsiro for a combined safety and efficacy endpoint at 1-year follow-up in allcomers. The low event rate in both groups suggests that both stents are safe, a...

Popular Science Recognizes Lockheed Martin's ONYX Exoskeleton and Miniature Hit-to-Kill ...

ORLANDO, Fla., Nov. 27, 2018 /PRNewswire/ -- Lockheed Martin's (NYSE: LMT) ONYX exoskeleton and Miniature Hit-to-Kill (MHTK) interceptor have been named to Popular Science's "Best Read more...

TCT: Studies Suggest Thin May not Always be In for DES

(MedPage Today) -- Resolute Onyx, BioFreedom on par with ultra-thin Orsiro stent

Medtronic Announces One-Month DAPT Clinical Study in the U.S. and Japan with Resolute Onyx DES in High Bleeding Risk Patients

The Onyx ONE Clear Study Builds Upon Body of Clinical Evidence to Inform Individualized DAPT Duration Following Stent Procedures DUBLIN - September 10, 2018 - Medtronic plc (NYSE:MDT) ...

MGC Pharmaceuticals - MGC Derma sale completed

Edison Investment Research - Pharmaceuticals & healthcare - MGC Pharmaceuticals: Key milestones for MGC Pharmaceuticals in 2019 include the launch of CannEpil sales in Australia, finalising contrac...

PTV News: Oct 13, 2009

Top stories on October 13th, 2009: Onyx aims for the top in Oncology Lupin's generic birth pills spark patent suits Novartis in transatlantic deals spree NICE work - the UK's healthcare watch...

Novel radiopaque stent offers better x-ray visibility

Results from the BIONYX Trial found the Resolute Onyx stent provided better x-ray visibility compared to Orsiro, an established cobalt-chromium strut stent, according to findings presented Monday, ...

Drugs and Medications [0 Results]

None

PubMed Articles [156 Associated PubMed Articles listed on BioPortfolio]

Embolization of brain arteriovenous malformations with the diluted Onyx technique: initial experience.

Insufficient nidus occlusion is a matter of great concern to routine Onyx embolization of brain arteriovenous malformations (AVMs). This paper described an efficient method which using the diluted Ony...

Characterization of six types of Mexican Onyx.

Optical, chemical, and radiation shielding characteristics of 6 types of Mexican onyx from the semi-desert of Zacatecas have been determined. Onyx samples are Yellow, Blue, Brown, Orange, Red and Gree...

Transarterial embolization of peripheral high-flow arteriovenous malformation with ethylene vinyl alcohol copolymer (Onyx): single-center 10-year experience.

High-flow arteriovenous malformations (AVMs) are complex vascular lesions for which transcatheter embolization is considered as first-choice treatment nowadays. Multiple embolizing agents have been de...

Transarterial Onyx embolization of residual AVM after surgical resection.

To report transarterial Onyx embolization of residual brain arteriovenous malformation (AVM) after surgical resection.

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Clinical Trials [249 Associated Clinical Trials listed on BioPortfolio]

IRIS-Onyx Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis

The objectives of this study are 1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Resolute Onyx™ stent. ...

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

RATIONALE: A specially modified virus called ONYX-015 may be able to kill tumor cells while leaving normal cells undamaged. Drugs used in chemotherapy use different ways to stop tumor cell...

Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)

Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%

RESOLUTE ONYX China Single Arm Study

It is a single arm clinical evaluation of safety and efficacy of the Medtronic Resolute Onyx™ zotarolimus-eluting coronary stent system in subjects who are eligible for percutaneous tran...

Companies [1357 Associated Companies listed on BioPortfolio]

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developi...

Onyx Pharmaceuticals

Onyx Pharmaceuticals, Inc. is engaged in the discovery and development of novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company's strategy is to capitali...

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Onyx Scientific Limited

Onyx Scientific is one of the fastest growing pharmaceutical service companies in the UK. We have more than 40 expert scientists specialising in drug development from medicinal chemistry to early stag...

Onyx Environmental Services

Onyx Environmental Services is the leading provider of environmental services in the United States. Our network of service centers, treatment, recovery and disposal facilities, sales offices and trans...

More Information about "Onyx Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Onyx Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Onyx Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Onyx Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Onyx Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Onyx Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record